BIAMONTE, FLAVIA
BIAMONTE, FLAVIA
Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells
2012 S. Bortoluzzi; A. Bisognin; M. Biasolo; P. Guglielmelli; F. Biamonte; R. Norfo; R. Manfredini; AM. Vannucchi
Epigenetics and mutations in chronic myeloproliferative neoplasms.
2011 A.M. Vannucchi;F. Biamonte
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis.
2010 P. Guglielmelli;F. Biamonte;A. Spolverini;L. Pieri;A. Isgrò;E. Antonioli;A. Pancrazzi;A. Bosi;G. Barosi;A.M. Vannucchi
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms.
2014 Rotunno G;Guglielmelli P;Biamonte F;Rumi E;Cazzola M;Vannucchi AM
MUTATIONS AND EPIGENETICS IN MYELOPROLIFERATIVE NEOPLASMS
2013 FLAVIA BIAMONTE
Mutations and prognosis in primary myelofibrosis.
2013 Vannucchi AM;Lasho TL;Guglielmelli P;Biamonte F;Pardanani A;Pereira A;Finke C;Score J;Gangat N;Mannarelli C;Ketterling RP;Rotunno G;Knudson RA;Susini MC;Laborde RR;Spolverini A;Pancrazzi A;Pieri L;Manfredini R;Tagliafico E;Zini R;Jones A;Zoi K;Reiter A;Duncombe A;Pietra D;Rumi E;Cervantes F;Barosi G;Cazzola M;Cross NC;Tefferi A
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
2011 Guglielmelli, Paola; Barosi, Giovanni; Rambaldi, Alessandro; Marchioli, Roberto; Masciulli, Arianna; Tozzi, Lorenzo; Biamonte, Flavia; Bartalucci, Niccolò; Gattoni, Elisabetta; Lupo, Maria Letizia; Finazzi, Guido; Pancrazzi, Alessandro; Antonioli, Elisabetta; Susini, Maria Chiara; Pieri, Lisa; Malevolti, Elisa; Usala, Emilio; Occhini, Ubaldo; Grossi, Alberto; Caglio, Silvia; Paratore, Simona; Bosi, Alberto; Barbui, Tiziano; Vannucchi, Alessandro M
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms.
2014 Tenedini E;Bernardis I;Artusi V;Artuso L;Roncaglia E;Guglielmelli P;Pieri L;Bogani C;Biamonte F;Rotunno G;Mannarelli C;Bianchi E;Pancrazzi A;Fanelli T;Malagoli Tagliazucchi G;Ferrari S;Manfredini R;Vannucchi AM;Tagliafico E.
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis.
2013 Susini MC;Guglielmelli P;Spolverini A;Biamonte F;Mannarelli C;Barosi G;Zoi K;Reiter A;Duncombe A;Cervantes F;Cazzola M;Cross N;Vannucchi AM.
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
2014 Guglielmelli P;Lasho TL;Rotunno G;Score J;Mannarelli C;Pancrazzi A;Biamonte F;Pardanani A;Zoi K;Reiter A;Duncombe A;Fanelli T;Pietra D;Rumi E;Finke C;Gangat N;Ketterling RP;Knudson RA;Hanson CA;Bosi A;Pereira A;Manfredini R;Cervantes F;Barosi G;Cazzola M;Cross NC;Vannucchi AM;Tefferi A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells | 2012 | S. Bortoluzzi; A. Bisognin; M. Biasolo; P. Guglielmelli; F. Biamonte; R. Norfo; R. Manfredini; AM. Vannucchi | |
| Epigenetics and mutations in chronic myeloproliferative neoplasms. | 2011 | A.M. Vannucchi;F. Biamonte | |
| Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis. | 2010 | P. Guglielmelli;F. Biamonte;A. Spolverini;L. Pieri;A. Isgrò;E. Antonioli;A. Pancrazzi;A. Bosi;G. Barosi;A.M. Vannucchi | |
| Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. | 2014 | Rotunno G;Guglielmelli P;Biamonte F;Rumi E;Cazzola M;Vannucchi AM | |
| MUTATIONS AND EPIGENETICS IN MYELOPROLIFERATIVE NEOPLASMS | 2013 | FLAVIA BIAMONTE | |
| Mutations and prognosis in primary myelofibrosis. | 2013 | Vannucchi AM;Lasho TL;Guglielmelli P;Biamonte F;Pardanani A;Pereira A;Finke C;Score J;Gangat N;Mannarelli C;Ketterling RP;Rotunno G;Knudson RA;Susini MC;Laborde RR;Spolverini A;Pancrazzi A;Pieri L;Manfredini R;Tagliafico E;Zini R;Jones A;Zoi K;Reiter A;Duncombe A;Pietra D;Rumi E;Cervantes F;Barosi G;Cazzola M;Cross NC;Tefferi A | |
| Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis | 2011 | Guglielmelli, Paola; Barosi, Giovanni; Rambaldi, Alessandro; Marchioli, Roberto; Masciulli, Arianna; Tozzi, Lorenzo; Biamonte, Flavia; Bartalucci, Niccolò; Gattoni, Elisabetta; Lupo, Maria Letizia; Finazzi, Guido; Pancrazzi, Alessandro; Antonioli, Elisabetta; Susini, Maria Chiara; Pieri, Lisa; Malevolti, Elisa; Usala, Emilio; Occhini, Ubaldo; Grossi, Alberto; Caglio, Silvia; Paratore, Simona; Bosi, Alberto; Barbui, Tiziano; Vannucchi, Alessandro M | |
| Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. | 2014 | Tenedini E;Bernardis I;Artusi V;Artuso L;Roncaglia E;Guglielmelli P;Pieri L;Bogani C;Biamonte F;Rotunno G;Mannarelli C;Bianchi E;Pancrazzi A;Fanelli T;Malagoli Tagliazucchi G;Ferrari S;Manfredini R;Vannucchi AM;Tagliafico E. | |
| The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. | 2013 | Susini MC;Guglielmelli P;Spolverini A;Biamonte F;Mannarelli C;Barosi G;Zoi K;Reiter A;Duncombe A;Cervantes F;Cazzola M;Cross N;Vannucchi AM. | |
| The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. | 2014 | Guglielmelli P;Lasho TL;Rotunno G;Score J;Mannarelli C;Pancrazzi A;Biamonte F;Pardanani A;Zoi K;Reiter A;Duncombe A;Fanelli T;Pietra D;Rumi E;Finke C;Gangat N;Ketterling RP;Knudson RA;Hanson CA;Bosi A;Pereira A;Manfredini R;Cervantes F;Barosi G;Cazzola M;Cross NC;Vannucchi AM;Tefferi A |